Best Mid Cap Funds
Tomorrow's large caps. Higher growth, higher swings — reward the patient.
Data updated · 34 direct-growth funds ranked by a transparent 0–100 Smart Score
| ⚖ VS | Fund | Score ↓ | Verdict | 1Y | 3Y | 5Y | Sharpe | Sortino | Std Dev | Alpha | Beta | VR★ | P/E | Expense | AUM | Age |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invesco India Midcap Invesco | 79 | Strong Buy | 0.9% | 21.2% | 16.8% | 0.84 | 1.19 | 20.1 | 7.0 | 1.01 | 5★ | 47.7 | 0.78% | ₹15.7k Cr | 13.8y | |
| WhiteOak Capital Mid Cap WhiteOak | 77 | Buy | 7.2% | 19.8% | — | 0.85 | 1.14 | 17.6 | 6.0 | 0.90 | 5★ | 30.4 | 0.95% | ₹7.5k Cr | 4.1y | |
| HSBC Midcap HSBC | 75 | Buy | 11.7% | 21.3% | 16.3% | 0.82 | 1.06 | 20.7 | 6.8 | 1.03 | 5★ | 33.1 | 1.15% | ₹16.8k Cr | 13.8y | |
| Helios Mid Cap Helios | 74 | Buy | 5.5% | — | — | 0.87 | 1.24 | 16.2 | 6.3 | 0.94 | — | 45.1 | 0.98% | ₹2.3k Cr | 1.6y | |
| Edelweiss Midcap Edelweiss | 72 | Buy | 1.5% | 18.9% | 15.8% | 0.77 | 0.36 | 18.4 | 4.8 | 0.95 | 5★ | 32.4 | 0.68% | ₹19.2k Cr | 13.8y | |
| HDFC Mid Cap HDFC | 70 | Buy | 1.1% | 15.3% | 16.4% | 0.64 | 0.79 | 16.1 | 2.2 | 0.83 | 4★ | 27.2 | 0.76% | ₹1.02L Cr | 13.8y | |
| Motilal Oswal Midcap Motilal Oswal | 68 | Buy | -4.7% | 17.1% | 18.6% | 0.62 | 0.96 | 21.2 | 3.8 | 0.95 | 4★ | 32.3 | 0.93% | ₹40.2k Cr | 12.6y | |
| Nippon India Gr Mid Cap Nippon India | 68 | Buy | 1.8% | 16.4% | 15.3% | 0.66 | 0.80 | 18.3 | 2.7 | 0.95 | 4★ | 26.8 | 0.80% | ₹50.2k Cr | 13.8y | |
| ICICI Pru Mid Cap ICICI Pru | 67 | Buy | 5.3% | 18.9% | 14.6% | 0.77 | 0.94 | 19.3 | 5.1 | 1.00 | 4★ | 34.3 | 1.11% | ₹8.0k Cr | 13.8y | |
| Baroda BNP Paribas Mid Cap Baroda BNP Paribas | 64 | Buy | 4.1% | 14.8% | 17.7% | 0.54 | 0.73 | 15.3 | 0.8 | 0.86 | 4★ | 28.0 | 0.78% | ₹2.5k Cr | 13.8y | |
| ITI Mid Cap ITI | 62 | Buy | 3.0% | 17.7% | 14.0% | 0.70 | 0.82 | 19.5 | 3.7 | 1.01 | 4★ | 31.5 | 0.91% | ₹1.5k Cr | 5.6y | |
| Mahindra Manulife Mid Cap Mahindra Manulife | 59 | Hold | 3.1% | 15.4% | 14.6% | 0.61 | 0.70 | 18.1 | 1.8 | 0.94 | 4★ | 33.0 | 0.75% | ₹5.1k Cr | 8.7y | |
| JM Mid Cap JM | 58 | Hold | 3.8% | 16.7% | — | 0.68 | 0.76 | 19.4 | 3.6 | 0.97 | 4★ | 36.1 | 0.95% | ₹1.3k Cr | 3.9y | |
| Bandhan Midcap Bandhan | 56 | Hold | 4.0% | 16.5% | — | 0.65 | -0.60 | 19.0 | 3.0 | 0.95 | 4★ | 46.8 | 0.76% | ₹2.5k Cr | 4.2y | |
| Sundaram Midcap Sundaram | 56 | Hold | 0.1% | 16.1% | 14.6% | 0.65 | 0.56 | 18.0 | 2.5 | 0.93 | 4★ | 35.0 | 1.05% | ₹13.9k Cr | 13.8y | |
| Axis Midcap Axis | 56 | Hold | 2.2% | 15.1% | 11.0% | 0.58 | 0.79 | 14.9 | 0.7 | 0.84 | 4★ | 32.1 | 0.84% | ₹33.6k Cr | 13.8y | |
| Canara Robeco Mid Cap Canara Robeco | 55 | Hold | 1.2% | 15.5% | — | 0.64 | 0.75 | 17.7 | 2.5 | 0.90 | 4★ | 39.3 | 0.86% | ₹5.0k Cr | 3.9y | |
| Mirae Asset Midcap Mirae Asset | 49 | Hold | 2.0% | 13.9% | 13.1% | 0.46 | 0.61 | 16.1 | -0.6 | 0.91 | 3★ | 23.5 | 0.97% | ₹19.5k Cr | 7.3y | |
| Union Midcap Union | 46 | Hold | 3.2% | 15.1% | 12.8% | 0.51 | 0.68 | 17.0 | 0.3 | 0.96 | 3★ | — | 1.11% | ₹1.9k Cr | 6.6y | |
| Kotak Midcap Kotak | 46 | Hold | -1.8% | 15.1% | 14.0% | -0.29 | -0.40 | 17.4 | -0.7 | 1.01 | 4★ | 30.2 | 0.54% | ₹67.0k Cr | 13.8y | |
| FranklIn India Mid Cap Franklin | 40 | Avoid | -3.0% | 13.6% | 11.2% | 0.46 | 0.62 | 15.6 | -0.6 | 0.88 | 3★ | 33.6 | 1.13% | ₹12.2k Cr | 13.8y | |
| Tata Mid Cap Tata | 40 | Avoid | 0.8% | 12.8% | 12.5% | 0.40 | 0.53 | 15.7 | -1.4 | 0.88 | 4★ | 34.7 | 0.86% | ₹5.9k Cr | 13.8y | |
| ABSL Midcap Aditya Birla Sun Life | 38 | Avoid | 2.4% | 13.2% | 11.5% | 0.43 | 0.58 | 15.8 | -1.0 | 0.88 | — | — | 1.23% | ₹6.6k Cr | 13.8y | |
| SBI Midcap SBI | 33 | Avoid | 0.3% | 9.2% | 11.3% | 0.20 | 0.27 | 13.5 | -4.0 | 0.74 | 3★ | 35.5 | 1.02% | ₹23.3k Cr | 13.8y | |
| DSP Midcap DSP | 31 | Avoid | -1.4% | 12.0% | 9.4% | 0.35 | 0.47 | 15.8 | -2.2 | 0.89 | 3★ | 21.4 | 0.84% | ₹19.5k Cr | 13.8y | |
| PGIM India Midcap PGIM India | 30 | Avoid | -3.7% | 10.2% | 8.6% | 0.25 | 0.34 | 15.3 | -3.7 | 0.85 | 2★ | 27.4 | 0.74% | ₹10.5k Cr | 12.9y | |
| LIC MF Mid Cap LIC | 28 | Avoid | 0.1% | 13.9% | 10.1% | 0.44 | 0.59 | 16.9 | -0.9 | 0.94 | 3★ | 37.5 | 1.77% | ₹369 Cr | 9.7y | |
| Quant Midcap Quant | 28 | Avoid | 0.9% | 9.5% | 13.5% | 0.18 | 0.24 | 17.1 | -4.8 | 0.90 | 4★ | 30.3 | 1.19% | ₹7.7k Cr | 13.8y | |
| Bank Of India Mid Cap Bank of India | 28 | Avoid | 1.5% | 12.4% | 10.2% | 0.38 | 0.50 | 15.7 | -1.6 | 0.86 | — | 28.8 | 1.32% | ₹729 Cr | 1.2y | |
| UTI Midcap UTI | 19 | Avoid | -0.5% | 10.4% | 10.1% | -0.31 | -0.42 | 17.2 | -1.9 | 1.00 | 3★ | 30.9 | 1.26% | ₹11.9k Cr | 13.8y | |
| Taurus Mid Cap Taurus | 14 | Avoid | 4.2% | 8.9% | 10.5% | 0.13 | 0.17 | 18.3 | -6.3 | 0.99 | — | — | 2.36% | ₹138 Cr | 13.8y | |
| TrustMF Mid Cap Trust | 9 | Avoid | — | — | — | — | — | — | — | — | — | 44.2 | 1.90% | ₹687 Cr | 0.6y | |
| The Wealth Company Mid Cap The Wealth Company | 7 | Avoid | — | — | — | — | — | — | — | — | — | 33.1 | — | ₹172 Cr | 0.2y | |
| Samco Mid Cap Samco | 6 | Avoid | — | — | — | — | — | — | — | — | — | 16.0 | 1.58% | ₹75 Cr | 0.7y |
Mid Cap funds — quick answers
›Which is the best Mid Cap mutual fund right now?
Invesco India Midcap currently ranks #1 of 34 Mid Cap funds with a FundLens Smart Score of 79/100 (Strong Buy). It returned 21.2% over 3 years and 16.8% over 5 years at a 0.78% expense ratio (direct plan). Rankings are recomputed from data updated 18 Oct 2026.
›Which Mid Cap fund has the best risk-adjusted returns?
Helios Mid Cap leads the category on the Sortino ratio at 1.24 (Sharpe 0.87) — meaning it has delivered the most return per unit of downside risk among Mid Cap funds.
›Which Mid Cap fund has the lowest expense ratio?
Kotak Midcap charges 0.54% a year (direct plan) — the lowest in the category. Lower fees compound in your favour over long holding periods.
›Which is the smallest Mid Cap fund by AUM?
Samco Mid Cap manages ₹75 Cr, the smallest in the category. Smaller funds can be nimbler, but check track record and costs before treating size alone as an edge.
›How long should I stay invested in a Mid Cap fund?
Mid Cap funds carry very high risk, so a horizon of 7+ years is generally sensible. Tomorrow's large caps. Higher growth, higher swings — reward the patient. This is research, not investment advice.
Visitors also asked
Want these answers conversationally? Ask FundLens · New to the ratios? Sharpe vs Sortino, explained